AnnJi Pharmaceutical News

Dedicated to New Drug Development in Dermatology & Neurology

AnnJi’s Company Presentation is Now Live at BIOAsia-Taiwan 2022

AnnJi is a clinical-stage pharmaceutical company focusing on developing innovative therapeutics to improve the quality of life of patients with dermatological and neurological diseases.

Watch online (below or BIOAsia-Taiwan 2022 if you have registered for the conference), for the latest update of our clinical projects: AJ101 for dermatology and AJ201 for rare neurological diseases. We are seeking product development partners for the global market.  Please contact us at info@www.ajpharm.com if you are interested in meeting with us.

Scroll to Top